# Shikonin-Loaded Nanoparticles Attenuate Particulate Matter-Induced Skin Injury by Inhibiting Oxidative Stress and Inflammation

**Authors:** Feifei Huang, Qinghua Tang, Ke Wang, Lingmei Zhou, Ruiwei Liao, Zhuoya Wang, Yan Li, Lin Zhou, Ming Li

PMC · DOI: 10.3390/antiox14111301 · 2025-10-29

## TL;DR

Shikonin-loaded nanoparticles reduce skin damage caused by fine particulate matter by reducing oxidative stress and inflammation.

## Contribution

A novel nanoparticle formulation of shikonin is developed to enhance its bioavailability and efficacy against PM2.5-induced skin injury.

## Key findings

- SH-NPs improved skin structure and reduced epidermal thickening and collagen fiber reduction in a mouse model.
- SH-NPs increased antioxidant enzymes and decreased markers of oxidative stress and inflammation in vivo.
- SH-NPs demonstrated high encapsulation efficiency and enhanced cellular uptake in HaCaT cells.

## Abstract

Exposure to fine particulate matter (PM2.5) poses a major threat to skin health, yet effective prevention strategies remain limited. Shikonin, a naphthoquinone derived from Lithospermum erythrorhizon, exhibits potent antioxidant and anti-inflammatory activities. However, its therapeutic application is limited by low bioavailability. To address this limitation, we developed shikonin-loaded nanoparticles (SH-NPs) using an emulsion solvent evaporation method and characterized their physicochemical properties. The protective effects of SH-NPs against PM2.5-induced skin damage were evaluated in a mouse model. The SH-NPs exhibited favorable characteristics, including a mean particle size of 209.03 ± 2.45 nm, a PDI of 0.064 ± 0.03, and a zeta potential of –17.69 ± 2.06 mV. The encapsulation efficiency is 88% and the drug loading capacity is 5.5%, respectively. In vitro, SH-NPs significantly enhanced cellular uptake in HaCaT cells. In vivo, treatment with SH-NPs significantly improved skin structural disorders, epidermal thickening, and collagen fiber reduction, while downregulating the expression of MMP-2 and MMP-9. Furthermore, SH-NPs increased the expression of SOD1 and SOD2, reduced MDA levels, and decreased the expression of TNF-α, IL-1β, and NO. In conclusion, SH-NPs attenuated PM2.5-induced skin toxicity via enhanced antioxidant, anti-inflammatory, and anti-degradation mechanisms, offering a novel strategy to boost shikonin bioavailability and prevent PM2.5-related skin damage.

## Linked entities

- **Genes:** MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], SOD1 (superoxide dismutase 1) [NCBI Gene 6647], SOD2 (superoxide dismutase 2) [NCBI Gene 6648], TNF (tumor necrosis factor) [NCBI Gene 7124], IL1B (interleukin 1 beta) [NCBI Gene 3553]
- **Chemicals:** Shikonin (PubChem CID 5208), MDA (PubChem CID 1614), NO (PubChem CID 24822)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** Skin Injury (MESH:D000069836), skin damage (MESH:D012871), Inflammation (MESH:D007249)
- **Chemicals:** Shikonin (MESH:C016101), naphthoquinone (MESH:D009285), NO (MESH:D009614), MDA (MESH:D015104), PM2.5 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Lithospermum erythrorhizon (species) [taxon 34254]
- **Cell lines:** HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12649448/full.md

---
Source: https://tomesphere.com/paper/PMC12649448